Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

IKT Stock Forecast, Price Targets, Chart, Dividends & Analysis

Inhibikase Therapeutics Inc logo

Inhibikase Therapeutics Inc

Sector: Manufacturing   

Industry: Biological Product (except Diagnostic) Manufacturing

1.30
 
USD
  
0.04
  
(3.17%)
Previous close: 1.26  Open: 1.31  Bid: 1.31  Ask: 1.37
52 week range    
0.80   
   3.82
Mkt Cap: 9 M  Avg Vol (90 Days): 335,346
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Friday 11th October 2024

Stock Rankings

51
MarketXLS Rank
80
Value
53
Technical
21
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ORTH-CA

OTIC

0.0085

OTLC

OVAT-CA

Financials

IKT Income Statement

Annual
Invalid dateDec-21Dec-22Dec-23
Basic EPS from continuing operations-0.81-4.28-3.57
Basic EPS total-0.81-4.28-3.57
Basic weighted shares outstanding18 M4 M5 M
Depreciation6723.0177398.0
DepreciationAndAmortization6723.0177398.0
Diluted EPS total-0.81-4.28-3.57
Diluted normalized net income/share-0.81-4.28-3.57
Diluted weighted shares outstanding18 M4 M5 M
GeneralAndAdministrativeExpense7 M6 M7 M
Gross operating profit3 M123440.0260501.0
Income before tax-15 M-18 M-19 M
InterestExpenseNonOperating19923.0-74453.0-1 M
MiscOtherSpecialCharges-688784.0
Net income from total operations-15 M-18 M-19 M
NetIncomeCommonStockholders-15 M-18 M-19 M
NetIncomeContinuousOperations-15 M-18 M-19 M
NetNonOperatingInterestIncomeExpense-19923.074453.01 M
Operating income-15 M-18 M-20 M
Operating income before depreciation (EBITDA)-15 M-18 M-20 M
OperatingExpense18 M18 M20 M
Other income net688784.0-104718.0103841.0
OtherGandA7 M6 M7 M
OtherOperatingExpenses56114.0141182.0
Research & development expense11 M12 M14 M
ResearchExpense11 M12 M14 M
Selling Gen & administrative expense7 M6 M7 M
Total Income available for interest expense (EBIT)-15 M-18 M-20 M
Total common shares outstanding25 M29 M6 M
Total net income-15 M-18 M-19 M
Total ordinary shares7 M7 M7 M
Total revenues3 M123440.0260501.0
TotalExpenses18 M18 M20 M
TotalRevenue3 M123440.0260501.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University